FindTrial
Sign In

stellate ganglion block with 0.5% bupivacaine

DRUG2 trials

Sponsors

Jonathann Kuo, MD, Antalya Training and Research Hospital

Conditions

COVID-19 RecurrentDysautonomiaDysautonomia Like DisorderDysautonomia Orthostatic Hypotension SyndromeLong COVIDLong Covid19Post Acute COVID-19 SyndromePost Acute Sequelae of COVID-19

Phase 1

Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
CompletedNCT05638620
Jonathann Kuo, MDCOVID-19 Recurrent, Dysautonomia, Dysautonomia Like Disorder +12
Start: 2023-01-03End: 2023-12-30Updated: 2025-03-13

Unknown Phase

Effects of Stellate Ganglion Block on Delirium and Circadian Rhythm in Geriatric Intensive Care Patients
Not yet recruitingNCT07558642
Antalya Training and Research HospitalStellate Ganglion Block
Start: 2026-08-06End: 2027-02-01Target: 130Updated: 2026-07-10